Compounded GHK-Cu vs OTC copper peptide serums: the concentration gap explained

Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP, FNP-BC. Last reviewed May 25, 2026.

The short answer

GHK-Cu is the same molecule whether it ships in a $35 Ordinary serum or a $100 compounded face cream. What differs is concentration and regulatory pathway. Mass-market OTC products deliver 0.05 to 0.1 percent GHK-Cu; compounded prescription products from a 503A pharmacy deliver 1 to 3 percent. The 30 to 60 times higher dose drives a measurable response in 8 to 12 weeks versus the 16 to 24 week timeline (or no measurable response) at OTC concentrations.

Side-by-side comparison

The concentration math

A 30mL OTC serum at 0.1 percent GHK-Cu contains 30 mg of active. A 30mL compounded prescription serum at 3 percent contains 900 mg of active. That is 30 times more active in the same bottle size.

Per-bottle pricing tells a misleading story:

• The Ordinary Multi-Peptide + Copper Peptides 1% Serum: roughly $35 for 30mL at less than 30 mg active. Cost per mg of GHK-Cu: approximately $1.17.
• RxPepsDirect Firm Boost Serum (3 percent): $120 for 30mL at 900 mg active. Cost per mg of GHK-Cu: approximately $0.13.

On a per-active-mg basis, compounded prescription is roughly nine times cheaper than the OTC serum despite the higher per-bottle price. The per-bottle premium reflects the regulatory pathway (provider, prescription, pharmacy, sterile compounding) rather than the molecule itself.

Why OTC disclosure is hard to read

Mass-market peptide serums often label total peptide content rather than per-molecule content. A "1% peptide complex" label can mean anything from 0.05 percent GHK-Cu plus 0.95 percent other peptides to 1 percent of one specific peptide. The disclosed percentages are not directly comparable across brands without reading the full ingredient list and looking up each peptide.

• The Ordinary Multi-Peptide + Copper Peptides 1%: the "1%" is the total peptide blend. Disclosed GHK-Cu fraction is below 0.1 percent.
• Biossance Squalane + Copper Peptide Rapid Plumping Serum: marketing-level disclosure only; estimated GHK-Cu content is in the 0.05 to 0.1 percent range.
• NIOD Copper Amino Isolate Serum 1%: the "1%" is total peptide complex; estimated GHK-Cu is below 0.2 percent.

Compounded prescription products disclose the exact concentration of each active by weight (3 percent GHK-Cu, 4 percent niacinamide, and so on). The Certificate of Analysis from the 503A pharmacy verifies the actual concentration in each batch.

Why the 503A pathway matters

The Federal Food, Drug, and Cosmetic Act draws a sharp line between cosmetic products and compounded medications. Cosmetics (the FDA category that includes OTC peptide serums) are limited to molecules and concentrations the FDA considers safe for unsupervised consumer use. The 0.05 to 0.1 percent ceiling on OTC copper peptide serums is partly because higher concentrations would require a prescription pathway.

Section 503A of the FFDCA authorizes state-licensed pharmacies to compound patient-specific prescriptions outside the cosmetic ceiling. A 503A pharmacy can dispense 3 percent GHK-Cu because:

• The patient has a prescription from a licensed provider.
• The pharmacy follows USP <797> sterile compounding standards.
• The active ingredient is on the FDA's bulk drug substances list for compounding.
• Provider oversight covers contraindication screening (copper allergy, Wilson's disease, active skin infection).

See the companion Are peptides legal in the United States in 2026? for the full statutory chain.

Real-world response timelines

Published dermatology data on GHK-Cu shows a clear dose-response relationship:

• At 0.05 to 0.1 percent (OTC range): subtle barrier and tone improvement over 16 to 24 weeks. Many users report no visible change at all.
• At 0.5 to 1 percent: measurable firmness and fine line softening over 12 to 16 weeks. The lower compounded threshold.
• At 2 to 3 percent (compounded range): visible firmness and tone improvement at 8 to 12 weeks. The pattern most RxPepsDirect patients report.

The compounded concentration is also what produces the brief "copper uglies" phase in the first 1 to 2 weeks: accelerated cellular turnover that can manifest as transient breakouts before the visible improvement appears. The OTC concentration is below the threshold that drives this turnover, which is why it produces neither the side effect nor the response.

When each makes sense

Choose OTC copper peptide if you are unwilling or unable to obtain a prescription, you want to experiment before committing to a provider visit, or you have very mild concerns and a long timeline. OTC is mechanistically valid; it just takes longer and produces less.

Choose compounded prescription GHK-Cu if you have measurable skin concerns (visible fine lines, loss of firmness, dullness), you want to see response in months rather than half-years, or you want to know exactly how much active is in each application. The flat $39 telehealth visit fee plus per-product wholesale pricing through Optimal Balance Pharmacy is roughly comparable to or cheaper than OTC on a per-active-mg basis.

The RxPepsDirect compounded GHK-Cu lineup

RxPepsDirect prescribes six GHK-Cu topical formulations through Optimal Balance Pharmacy:

• Cashmere Cream (3 percent GHK-Cu, 4 percent niacinamide) $45 / 30g. The entry-tier daily moisturizer.
• Firm Boost Serum (3 percent GHK-Cu, 3 percent niacinamide) $120 / 30mL.
• Biocosmetic Cream (3 percent GHK-Cu, 0.003 percent estriol) $100 / 30g. Mature skin.
• Biocosmetic + SNAP-8 Cream $120 / 30g. Adds expression-line targeting.
• GHK-Cu SNAP-8 Niacinamide Serum $140 / 30mL. The serum-format combo.
• GHK-Cu 1% Hair Restoration Solution $100 / 30mL.

See the Topical GHK-Cu protocol guide for the full mechanism and selection walkthrough.

Bottom line

OTC copper peptide serums contain a mechanistically valid molecule at sub-clinical concentrations. Compounded prescription GHK-Cu contains the same molecule at 10 to 60 times the active dose. On a per-active-mg basis the compounded path is roughly comparable or cheaper than OTC. The visible-response timeline at compounded concentration is 8 to 12 weeks; at OTC concentration it stretches to 16 to 24 weeks or no measurable response at all.

See all Skin and Hair topicals→